Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Fortive Corporation's published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $17.5B | |
|---|---|---|
| Revenue (ttm) | 4.3B | |
| Net income (ttm) | 534.4M | |
| EPS (ttm) | $1.68 | |
| Shares out | 302M | |
| P/E (trailing) | 37.9x | |
| P/E (forward) | 17.3x | |
| Dividend | $0.28 (0.44%) | |
| Volume | 5,333,165 | |
| Beta | 0.99 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $5.25B | $5.83B | $3.91B | $4.08B | $4.16B | -5.7% |
| Gross profit | $3.01B | $3.36B | $2.48B | $2.62B | $2.64B | -3.2% |
| Operating income | $812.8M | $987.4M | $574.0M | $716.3M | $720.2M | -3.0% |
| Net income | $608.4M | $755.2M | $865.8M | $832.9M | $579.2M | -1.2% |
| EPS (diluted) | $1.23 | $1.58 | $2.43 | $2.36 | $1.73 | +8.9% |
| EBITDA | $1.18B | $1.44B | $1.13B | $1.67B | $1.20B | +0.5% |
| R&D | $354.8M | $401.5M | $237.0M | $251.3M | $259.2M | -7.5% |
| SG&A | $1.84B | $1.96B | $1.67B | $1.65B | $1.66B | -2.5% |
Recent company headlines from major financial publishers.
The base case projects intrinsic value reaching $52.99 with an assigned probability of 60.0%, offering an implied return of -7.5% relative to $57.26 (as of 2026-10-09). This trajectory assumes steady mid-single-digit organic growth across Intelligent Operating Solutions, continuous Fortive Business System operational improvements expanding operating margins through FY2030, and disciplined share repurchases. Disconfirmation would occur if segment operating margins deteriorate or if industrial capex freezes in North America and EMEA.
The bull case models upside reaching $60.16 with a probability of 20.0%, generating an implied return of 5.1% from $57.26 (as of 2026-10-09). This outcome requires accelerated conversion of legacy hardware clients into recurring cloud software subscriptions within Intelligent Operating Solutions, accompanied by stronger hospital procedure volumes in healthcare sterilization. Faster margin expansion toward Potential value of $60.16 would be disconfirmed if peer competition limits software pricing power.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.4% | $56.7 | $57.6 | $58.6 | $59.6 | $60.8 |
| 8.9% | $54.0 | $54.8 | $55.6 | $56.4 | $57.4 |
| 9.4% | $51.7 | $52.3 | $53.0 | $53.7 | $54.5 |
| 9.9% | $49.6 | $50.1 | $50.7 | $51.3 | $52.0 |
| 10.4% | $47.7 | $48.2 | $48.7 | $49.2 | $49.8 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
